Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.34
+0.35 (3.18%)
At close: Mar 25, 2026, 4:00 PM EDT
11.58
+0.24 (2.12%)
After-hours: Mar 25, 2026, 7:20 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $223.6 million as of March 25, 2026. Its market cap has decreased by -49.50% in one year.
Market Cap
223.60M
Enterprise Value
-46.94M
1-Year Change
-49.50%
Ranking
Category
Stock Price
$11.34
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $223.60M, a decrease of -41.97%. That is a compound annual growth rate of -8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 216.70M | -65.07% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 235.19M |
| Voyager Therapeutics | 233.63M |
| Alector | 229.55M |
| Tenax Therapeutics | 227.52M |
| Cybin | 225.66M |
| Sol-Gel Technologies | 222.92M |
| Editas Medicine | 220.21M |
| Eledon Pharmaceuticals | 219.21M |